Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:05 AM
Ignite Modification Date:
2025-12-25 @ 1:05 AM
NCT ID:
NCT01200693
Eligibility Criteria:
Inclusion Criteria:
* de novo bifurcated lesions
* lesions \>50% located in a major bifurcation point
* TIMI \>2 on both main vessel and side branch
* main vessel visual diameter \>2.5 mm
* side branch visual diameter \>2.0 mm
* \>18 years of age
* signed the informed consent to enter the study
Exclusion Criteria:
* known hypersensitivity to Sirolimus, Everolimus, cobalt, chromium, nickel, tungsten acrylic and fluoro-polymers
* contraindications to double antiplatelet therapy acute (within 48 hours) ST-elevation acute myocardial infarction
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
85 Years
Study:
NCT01200693
Study Brief:
Protocol Section:
NCT01200693